Aicaigou LogoB2B Wiki

Spherical Tablet

Updated: 2026-08-29

Overview

Spherical tablets are advanced solid dosage forms manufactured through specialized processes like extrusion-spheronization or fluid bed coating. These spherical pellets offer distinct advantages over conventional tablets, including improved patient compliance (particularly for pediatric and geriatric use), better content uniformity, and flexibility in designing controlled-release profiles. In pharmaceutical development, spherical tablets enable combination therapies through multiparticulate systems, where pellets with different release characteristics can be blended. The technology is also valued in nutraceuticals for creating uniform nutrient delivery systems and in veterinary medicine for precise dosing in animal feed.

Physical and Chemical Properties

The physical properties of spherical tablets are carefully engineered, with typical diameters ranging from 0.5mm for microspheres to 3mm for macro-pellets. Surface smoothness (measured by sphericity index) and mechanical strength (friability <1%) are critical quality parameters that affect downstream processing and performance. Chemically, these systems comprise an active pharmaceutical ingredient (API) embedded in excipient matrices, often including microcrystalline cellulose as a spheronization aid. Coating systems may incorporate polymers like ethylcellulose for sustained release or enteric materials such as HPMC phthalate for targeted delivery. The composition directly influences dissolution behavior, with some formulations designed for immediate release within 30 minutes and others for prolonged release over 12-24 hours.

Main Applications

In pharmaceuticals, spherical tablets dominate certain therapeutic areas: proton pump inhibitors (e.g., omeprazole pellets) use enteric coating for gastric protection, while opioid analgesics employ sustained-release pellets for steady pain management. Multiparticulate systems are particularly valuable for drugs with narrow therapeutic windows, as they reduce dose-dumping risks compared to monolithic tablets. The nutraceutical industry utilizes spherical tablets for vitamin/mineral combinations, probiotics, and herbal extracts, where the technology ensures stability of sensitive compounds. Industrial applications include enzyme preparations for detergents and agricultural products like pesticide pellets for controlled environmental release.

Safety and Storage

Handling spherical tablets requires attention to particulate matter control, especially during bulk transfer operations where dust generation may occur. Facilities should implement appropriate containment strategies and personal protective equipment (PPE) when working with potent APIs in pellet form. Storage conditions must maintain pellet integrity—excessive moisture can cause agglomeration, while extreme dryness may increase friability. For hygroscopic formulations, packaging with desiccants is recommended. Stability studies typically confirm 24-36 month shelf life under proper storage, though coated products may require specific humidity controls to prevent coating defects.

B2B Procurement Guide

When sourcing spherical tablets, buyers should verify the manufacturer's capability in analytical testing (dissolution profile characterization, particle size distribution analysis) and process validation documentation. Key specifications to negotiate include pellet size distribution (e.g., 90% within 1.0-1.8mm), drug content uniformity (RSD <5%), and dissolution criteria matched to pharmacopeial standards. For custom formulations, expect lead times of 12-20 weeks for development and scale-up. Bulk procurement (100kg+) typically offers 15-25% cost advantages versus small batches. Quality audits should assess the supplier's ability to handle containment for potent compounds and cross-contamination prevention measures for multi-product facilities.

Related Manufacturers